Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Consulting agrmnt
Inv. presentation
Quarterly results
Asset acq. complete
Director departure
CC transcript
Asset disposition
Acq. announced

Protagenic Therapeutics, Inc.\new (PTIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Bought 23,000 shares @ $0.71, valued at $16.3k
Bought 8,000 shares @ $0.72, valued at $5.8k
06/03/2021 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Bought 100 options to buy @ $4.98, valued at $498
Bought 16,900 options to buy @ $4.98, valued at $84.2k
06/01/2021 4 Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 180,000 options to buy @ $0
06/01/2021 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Bought 3,000 options to buy @ $4.98, valued at $14.9k
05/20/2021 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Bought 12,000 options to buy @ $4.98, valued at $59.8k
Bought 18,000 options to buy @ $4.98, valued at $89.6k
05/05/2021 4 Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Exercised 45,000 options to buy @ $1.25, valued at $56.3k
Exercised 150,000 options to buy @ $1.25, valued at $187.5k
Exercised 45,000 options to buy @ $1.75, valued at $78.8k
Exercised 120,000 options to buy @ $1.75, valued at $210k
05/03/2021 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Bought 1,000 shares @ $2.29, valued at $2.3k
Bought 1,000 shares @ $2.29, valued at $2.3k
07/21/2020 4 Buell Jennifer (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 145,000 options to buy @ $1.75, valued at $253.8k
07/21/2020 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 124,998 options to buy @ $1.75, valued at $218.7k
02/26/2020 4 Stein Robert Benjamin (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 150,000 options to buy @ $1.75, valued at $262.5k
02/26/2020 4 Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 120,000 options to buy @ $1.75, valued at $210k
02/26/2020 4 Silverman Joshua (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 120,000 options to buy @ $1.75, valued at $210k
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 4 Corvese Brian (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 120,000 options to buy @ $1.75, valued at $210k
02/26/2020 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 307,497 options to buy @ $1.75, valued at $538.1k
03/25/2019 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 41,667 options to buy @ $1, valued at $41.7k
10/18/2017 4 Corvese Brian (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 95,000 options to buy @ $1.75, valued at $166.3k
10/18/2017 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 75,000 options to buy @ $1.75, valued at $131.3k
10/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2017 4 Stein Robert Benjamin (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 200,000 options to buy @ $1.75, valued at $350k
10/18/2017 4 Silverman Joshua (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 45,000 options to buy @ $1.75, valued at $78.8k
10/18/2017 4 Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 45,000 options to buy @ $1.75, valued at $78.8k
08/18/2016 4 ARMEN GARO H (See Remarks) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Bought 60,211 shares @ $1.25, valued at $75.3k
08/10/2016 4 Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
06/22/2016 4 Ekizian Gregory (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 45,000 shares @ $1.25, valued at $56.3k
06/21/2016 4 Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
Txns: Granted 140,000 shares @ $1.25, valued at $175k
06/21/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2016 4 Silverman Joshua (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
06/21/2016 4 Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
06/21/2016 4 Stein Robert Benjamin (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new
05/10/2016 4 Arrow Alexander K. (CFO) has filed a Form 4 on Atrinsic, Inc.
Txns: Bought 40,000 preferred shares @ $1.25, valued at $50k
Bought 18,260 preferred shares @ $1.25, valued at $22.8k
06/02/2011 4 BRILLIANT DIGITAL ENTERTAINMENT INC (10% Owner) has filed a Form 4 on Atrinsic, Inc.
12/15/2010 4 MUSCI RAYMOND (Exec VP, Corporate Development) has filed a Form 4 on Atrinsic, Inc.
Txns: Bought 200 shares @ $1.59, valued at $318
Bought 300 shares @ $1.6, valued at $480
Bought 600 shares @ $1.63, valued at $978
Bought 100 shares @ $1.64, valued at $164
Bought 100 shares @ $1.7, valued at $170
Bought 3,499 shares @ $1.79, valued at $6.3k
Bought 5,000 shares @ $1.9, valued at $9.5k
Bought 266 shares @ $1.97, valued at $524
Bought 900 shares @ $1.98, valued at $1.8k
Bought 1,334 shares @ $1.99, valued at $2.7k
Bought 74 shares @ $2, valued at $148
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy